Skip to main content

Jordi Mollet Sánchez

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Jordi Mollet Sánchez

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Implementación de un proceso asistencial automatizado para el diagnóstico precoz de artritis psoriásica en pacientes con psoriásis: Proyecto multidisciplinar entre atención primaria y atención hospitalaria

IP: María Alba Erra Duran
Collaborators: Juan Jose De Agustin De Oro, Jordi Mollet Sánchez, Yolima Cossio Gil, Emmanuel Giménez García, Gloria Aparicio Español, Luis Coronel Tarancon
Funding agency: Instituto de Salud Carlos III
Funding: 57500
Reference: PI25/01718
Duration: 01/01/2026 - 31/12/2028

Linfocitos T CD8 e infecciones del sistema nervioso como iniciadores y propagadores de la enfermedad de Parkinson: hacia la estratificación de pacientes en base a biopsias de tejido periférico

IP: Jordi Bove Badell
Collaborators: Oscar Len Abad, Jordi Mollet Sánchez, Xavier Serres Créixams, Oriol de Fabregues-Boixar Nebot, Maria Piñana Moro, Maria Teresa Buongiorno
Funding agency: Instituto de Salud Carlos III
Funding: 221250
Reference: PI24/01820
Duration: 01/01/2025 - 31/12/2027

Investigación del mecanismo de acción de la Talidomida en el Lupus Discoide para el desarrollo de nuevas terapias

IP: Josefina Cortes Hernandez
Collaborators: Maria Carme Dinarès Fernández, Jordi Mollet Sánchez, Cristina Solé Marce
Funding agency: Instituto de Salud Carlos III
Funding: 104665
Reference: PI15/02145
Duration: 01/01/2016 - 31/12/2019

Lupus eritematoso discoide: disección por microarray

IP: Josefina Cortes Hernandez
Collaborators: Jordi Mollet Sánchez, José Ordi Ros, Berta Ferrer Fábrega
Funding agency: Instituto de Salud Carlos III
Funding: 109142
Reference: PI10/02234
Duration: 01/01/2011 - 30/09/2014

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Nuria  Roson  Gradaille

Nuria Roson Gradaille

Research technician
Molecular Imaging and Therapy
Read more
Maria Pieras Lopez

Maria Pieras Lopez

Senior researcher
Infection and immunity in pediatric patients
Read more
Teresa Soriano Sánchez

Teresa Soriano Sánchez

Senior researcher
Cardiovascular Diseases
Read more
Luis Ignacio Soto Bargaria

Luis Ignacio Soto Bargaria

Predoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.